While TB-500 has compelling animal data, theres almost no research performed on the peptide in humans
It was added to the Prohibited List in 2022 as a non-approved substance, reflecting its transition from an obscure research compound to a significant "substance of interest" in professional athletics
Swab everything
The slower absorption profile of subcutaneous delivery suits BPC-157's mechanism: as a tissue-signaling peptide, it benefits from sustained presence in circulation rather than rapid spikes
Zhang, M., Yu, Y., Lian, L., Li, W., Ren, J., Liang, Y., et al., Probiotics Antimicrob
Of note, 25% of our cohort met eligibility criteria for a recent semaglutide trial in obese non-diabetics with pre-existing cardiovascular disease